B-cell CD19 Kappa Light Chain Positive Cells (Absolute Count)
This test measures the number of B cells that express the CD19 marker and produce kappa light chains in your blood. It may be used to assess immune function or monitor conditions affecting B cells.
["This test helps evaluate immune health or diagnose certain blood disorders."]
Key facts at a glance
- LOINC
- 26565-2
- Short code
- CD19K
- Synonyms
- CD19+Kappa+ Cells NFr Spec
- Category
- chemistry
- Sample
- serum
- Container
- EDTA (lavender-top) tube for peripheral blood; sterile collection container for bone marrow or other tissue specimens
- Units
- N/A
- Ref low
- 0.5
- Ref high
- 2
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- 18–65 years
- Method
- Flow cytometry immunophenotyping using fluorescently labeled antibodies against CD19 surface marker and kappa light chain
- CPT
- 86356
- SNOMED
- 269809005
- Specimen volume
- 1-3 mL of peripheral blood in EDTA tube; minimum 0.5 mL for pediatric samples
- Stability
- Specimen should be processed within 24-48 hours of collection. Store at room temperature (18-25°C). Do not refrigerate or freeze as this may affect cell viability and surface marker expression.
- Hemolysis max
- 500
- Lipemia max
- 1000
- Icterus max
- 500
- TAT
- 24–72 hours
- Order
- routine
What Does This Test Measure?
The test identifies a specific subset of white blood cells (B cells) that have markers (CD19) and light chains (kappa) on their surface. These cells are part of the immune system and play a role in producing antibodies. The absolute count reflects the proportion of these cells in your bloodstream.
Why Might This Test Be Ordered?
Your healthcare provider may order this test if you have symptoms or conditions that could involve abnormal B-cell activity, such as certain autoimmune diseases, infections, or blood disorders. It may also be part of a broader immune evaluation.
Sample Collection and Preparation
A blood sample is drawn from a vein, typically in your arm. The blood is processed to separate the cells, and the test measures the specific subset of B cells as described. No special preparation is needed, but fasting may not be required unless specified by your provider.
What Are Possible Results?
Results are expressed as the absolute number of CD19+ kappa light chain-positive B cells per microliter (µL) of blood. Interpretation depends on clinical context, including your overall health and symptoms. Your healthcare provider will discuss these results with you.
Reference range
CD19+ B-cells with kappa light chain restriction are interpreted in the context of total B-cell count and kappa/lambda ratio. Normal kappa/lambda ratio is approximately 0.5-2.0 in polyclonal B-cell populations. Reference ranges vary by laboratory; results should be interpreted alongside total CD19+ B-cell count.N/A
No special patient preparation required. Recent corticosteroid therapy, chemotherapy, or immunosuppressive medications may affect B-cell counts and should be documented.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
◆Associated findings1
Short name
CD19+ Kappa Light Chain+ B Cells
Frequently asked questions
How is this test different from a general B-cell count?
What conditions might affect this test result?
Can this test be done at home?
Sources
- 1
- 2Lab Tests OnlineSource
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy